Zealand Pharma A/S ZLDPF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -49.44% | 371.85% | 729.97% | 1,093.48% | 27,970.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -49.44% | 371.85% | 729.97% | 1,093.48% | 27,970.28% |
| Cost of Revenue | -- | -- | -100.00% | -- | -- |
| Gross Profit | -49.44% | 371.85% | 769.12% | 377.51% | 38,779.66% |
| SG&A Expenses | 6.92% | 13.20% | -34.98% | 116.26% | 44.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.79% | 53.66% | 66.10% | 54.86% | 161.98% |
| Operating Income | -52.65% | -47.39% | -51.04% | -41.62% | 3,383.83% |
| Income Before Tax | -49.47% | -30.19% | -52.04% | -45.59% | 3,007.75% |
| Income Tax Expenses | -83.04% | -- | -5,106.46% | 2,999.51% | 43,114.64% |
| Earnings from Continuing Operations | -47.09% | -30.58% | -42.07% | -61.31% | 2,827.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.09% | -30.58% | -42.07% | -61.31% | 2,827.45% |
| EBIT | -52.65% | -47.39% | -51.04% | -41.62% | 3,383.83% |
| EBITDA | -52.58% | -46.46% | -51.37% | -41.94% | 3,471.77% |
| EPS Basic | -46.81% | -30.71% | -42.84% | -62.14% | 2,517.60% |
| Normalized Basic EPS | -49.67% | -17.71% | -64.65% | -42.26% | 2,596.06% |
| EPS Diluted | -46.39% | -30.71% | -42.82% | -62.14% | 2,484.19% |
| Normalized Diluted EPS | -49.27% | -17.71% | -64.65% | -42.26% | 2,561.55% |
| Average Basic Shares Outstanding | -0.53% | -0.09% | -0.54% | -0.51% | 12.82% |
| Average Diluted Shares Outstanding | -1.31% | -0.09% | -0.54% | -0.51% | 14.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |